Survival of differentiated thyroid carcinoma studied in 500 patients

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2067-2075

  Lerch, H ^a   Schober, O ^a   Kuwert, T ^a   Saur, H B ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

EID: 0031004471     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.2067     Document Type: Article

References (44)

1. Benker G, Olbricht TH, Reinwein D, et al: Survival rates in patients with differentiated thyroid carcinoma. Cancer 65:1517-1520, 1990
2. Byar DP, Green SB, Dor P, et al: A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer Clin Oncol 15:1033-1041, 1979
3. Mazzaferri EL, Young RL: Papillary thyroid carcinoma: A 10 year follow up report of the impact of therapy in 576 patients. Am J Med 70:511-518, 1981
4. McConahey WM, Hay ID, Woolner LB, et al: Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978-996, 1986
5. Philips P, Hanzen C, Andry G, et al: Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 19:399-404, 1993
6. Scheumann GFW, Grimm O, Wegener G, et al: Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559-565, 1994
7. Tubiana M, Haddad E, Schlumberger M, et al: External radiotherapy in thyroid cancers. Cancer 55:2062-2071, 1985
8. Freitas JE, Gross MD, Ripley S, et al: Radionuclide diagnosis and therapy of thyroid cancer: Current status report. Semin Nucl Med 15:106-131, 1985
9. Pacini F, Cetani F, Miccoli P, et al: Outcome of 309 patients with metastastic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18:600-604, 1994
10. Schober O, Saur HB, Sciuk J, et al: Radioiodine therapy of malignant thyroid disease. Exp Clin Endocrinol 102:55-66, 1994
11. Goretzki PE, Simon D, Frilling A, et al: Surgical reintervention for differentiated thyroid cancer. Br J Surg 80:1009-1012, 1993
12. Maxon HR, Smith HS: Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metabol Clin North Am 19:685-718, 1990
13. Schlumberger M, Tuniani M, De Vathaire F, et al: Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinomas. J Clin Endocrinol Metab 63:969-976, 1986
14. Young RL, Mazzaferri EL, Rahe AJ, et al: Pure follicular thyroid carcinoma: Impact of therapy in 214 patients. J Nucl Med 21:733-737, 1980
15. DeGroot LJ, Kaplan EL, McCormick M, et al: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424, 1990
16. DeGroot LJ, Kaplan EL, Shukla MS, et al: Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80:2946-2953, 1995
17. Hay ID, Bergstrahl EJ, Goellner JR, et al: Presentation and prognosis in 1228 differentiated thyroid cancers: Are there clinically important distinctions between typical (non-oxyphilic) papillary and follicular tumors? J Endocrinol Invest 16:35-37, 1993 (suppl 6)
18. Shah JP, Loree TR, Dharker D, et al: Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched-pair analysis. Am J Surg 166:331-335, 1993
19. Hay ID, Grant CS, Taylor WF, et al: Ipsilateral lobectomy versus lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1094, 1987
20. Hay ID, Grant CS, van Heerden JA, et al: Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50 year period. Surgery 112:1139-1146, 1992
21. Emerick GT, Duh QY, Siperstein AE, et al: Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 72:3287-3295, 1993
22. DeGroot LJ, Kaplan EL: Second operations for "completion" of thyroidectomy in treatment of differentiated thyroid cancer. Surgery 110:936-939, 1991
23. Eroglu A, Berberoglu U, Buruk F, et al: Completion thyroidectomy for differentiated thyroid carcinoma. J Surg Oncol 59:261-266, 1995
24. Ley PB, Roberts JW, Symmonds RE Jr, et al: Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: A 20 year review. Am Surg 59:110-114, 1993
25. DeJong SA, Demeter JG, Lawrence AM, et al: Necessity and safety of completion thyroidectomy for differentiated thyroid carcinoma. Surgery 112:734-739, 1992
26. Mazzaferri EL, Jhiang SM: Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428, 1994
27. DeGroot LJ: Long term impact of initial and surgical therapy on papillary and follicular thyroid cancer. Am J Med 97:499-500, 1994 (editorial)
28. Glanzmann CH, Lütolf UM: Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment. Strahlenther Onkol 168:260-269, 1992
29. 131). Ann Surg 219:587-593, 1994
30. Samaan NA, Schultz P, Hickey RC, et al: The results of various modalities of treatment of well differentiated thyroid carcinoma: A retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720, 1992
31. Pasieka JL, Rotstein LE: Consensus conference on well differentiated thyroid cancer: A summary. Can J Surg 36:298-301, 1993
32. DeGroot LJ, Kaplan EL, Straus FH, et al: Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 18:123-130, 1994
33. Hay ID, Bergstrahl EJ, Goellner JR, et al: Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic score system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058, 1993
34. Simpson WJ, Panzarella T, Carruthers S, et al: Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14:1063-1075, 1988
35. Beahrs OH, Henson DE, Hutter RVP, et al: Manual for Staging of Cancer. Philadelphia, PA, American Joint Comission on Cancer, 1988
36. Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-952, 1988
37. Brennan MD, Bergstralh EJ, van Heerden JA, et al: Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66:11-22, 1991
38. Harwood J, Clark OH, Dunphy JE: Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 136:107-112, 1978
39. Farahati J, Reiners C, Stuschke M, et al: Differentiated thyroid cancer: Impact of external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77:172-180, 1996
40. Simpson WJ: Radioiodine and radiotherapy in the management of thyroid cancers. Otolaryngol Clin North Am 23:509-521, 1990
41. Ozata M, Suzuki S, Miyamoto T, et al: Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98-105, 1994
42. Pineda JD, Lee T, Reynolds JC, et al: Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 80:1488-1492, 1995
43. Mazzaferri EL: Treating high thyroglobulin with radioiodine: A magic bullet or a shot in the dark? J Clin Endocrinol Metab 80:1485-1497, 1995 (editorial)
44. Wong JB, Kaplan MM, Meyer KB, et al: Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol Metab Clin North Am 19:741-760, 1990